BSE filing, NSE: INDOCO. Summary written from the filing by ALFA Finder's alert engine.
Indoco Remedies Ltd: key numbers
- Share price
- ₹209.50
- Market cap
- ₹1,934 Cr
- Revenue (annual)
- ₹1,845 Cr
- Net profit (annual)
- ₹-95.14 Cr
- P/E (TTM)
- 60.5×Sector 48.7×
- Promoter holding
- 58.92%+0.06% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indoco Remedies Ltd
All →Indoco Remedies Earnings Call Transcript: Key Takeaways
Indoco Remedies hit record quarterly revenue exceeding ₹500 Cr, but faced margin compression from elevated geopolitical freight and material costs.
- Call
- Guides 10% growth
Indoco Remedies Business Update
Indoco's CRO AnaCipher received ANVISA Brazil approval for clinical and bioanalytical facilities. This expands its regulatory footprint to conduct bioequivalence studies in Brazil and Latin America.
Indoco Remedies Q2 FY27 Results: Turns Profitable, Net Profit ₹19.5 Cr
Indoco Remedies Ltd reported revenue from operations of ₹506.9 Cr (+7.4% YoY) and net profit of ₹19.5 Cr for Q2 FY27.
- Key figure
- Net profit ₹19.5 Cr
Indoco Remedies Employee Stock Options
Indoco Remedies allotted 14,850 ESOP shares to its Employees Welfare Trust under the 2022 ESOP plan. The allotment is at face value with no transaction price.
Indoco Remedies Other Announcement
Indoco Remedies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI Regulation 31(1)(b).
Indoco Remedies Merger & Restructuring Worth ₹0.01 Cr
Indoco Remedies Limited is incorporating a new wholly owned subsidiary, Warren Lifesciences Private Limited, for a cash investment of ₹0.01 Crore.
- Value
- ₹0.01 Cr
Other board meeting date announcements
All →Ajwa Fun World & Resorts Board Meeting Date
Ajwa Fun World & Resort schedules a 4 November 2026 board meeting for quarterly results and a secretarial auditor appointment. No monetary amount is disclosed.
Prashant India Board Meeting Date
Prashant India Ltd scheduled a board meeting for November 5, 2026, to consider and approve the standalone unaudited financial statements for the quarter ended September 2026.
Metalic Technoforge Board Meeting Date
Metalic Technoforge Limited scheduled a board meeting for November 4, 2026, to consider and approve its unaudited half-yearly financial results.
G G Dandekar Properties Board Meeting Date
G. G. Dandekar Properties Ltd has scheduled a board meeting for November 4, 2026, to approve its financial results for the quarter and half-year ended September 30, 2026.
Jyoti CNC Automation Board Meeting Date
Jyoti CNC Automation Ltd will hold a board meeting on November 03, 2026, to approve standalone and consolidated financial results for the quarter ended September 30, 2026.
Generic Engineering Construction and Projects Board Meeting Date
Generic Engineering Construction and Projects Ltd scheduled a board meeting on November 3, 2026. The meeting will consider standalone and consolidated quarterly financial results.